Citadel Advisors’s AfterNext HealthTech Acquisition Corp Warrants AFTR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-625,091
Closed -$263K 14555
2022
Q1
$263K Buy
625,091
+92
+0% +$50 ﹤0.01% 10897
2021
Q4
$437K Buy
+624,999
New +$511K ﹤0.01% 10014

Other funds holding AFTR.WS

Citadel Advisors's AFTR.WS Position: Q2 2022 in Review

Citadel Advisors sold out of AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) in Q2 2022, closing a stake of 625,091 shares — an estimated $263K sold.

Citadel Advisors first reported a position in AFTR.WS in Q4 2021 and held it in 2 quarters. The position peaked at $437K in Q4 2021. 22 funds tracked by Wall St. Rank hold AFTR.WS as of Q2 2022.

  • Citadel Advisors reported no remaining AfterNext HealthTech Acquisition Corp Warrants position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 625,091 AfterNext HealthTech Acquisition Corp Warrants shares in Q2 2022, an estimated $263K.
  • Citadel Advisors first reported a position in AfterNext HealthTech Acquisition Corp Warrants in Q4 2021 and held it in 2 quarters.
  • Citadel Advisors's AfterNext HealthTech Acquisition Corp Warrants position peaked at $437K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Warrants as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.